BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14534746)

  • 1. Immunohistochemical profile and treatment of uncommon types of thyroid carcinomas.
    Shvero J; Koren R; Shpitzer T; Feinmesser R; Segal K
    Oncol Rep; 2003; 10(6):2075-8. PubMed ID: 14534746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
    Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
    Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ; McKeown-Eyssen G; Asa SL
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
    Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
    Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin expression profiles in thyroid carcinomas.
    Lam KY; Lui MC; Lo CY
    Eur J Surg Oncol; 2001 Nov; 27(7):631-5. PubMed ID: 11669590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases.
    Ordóñez NG; El-Naggar AK; Hickey RC; Samaan NA
    Am J Clin Pathol; 1991 Jul; 96(1):15-24. PubMed ID: 1712540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Undifferentiated carcinomas of the thyroid corpus. Apropos of 10 cases].
    Habib K; Auriol M; Sarfati E; de Roquancourt A; Wann AR; Brocheriou C; Chomette G
    Arch Anat Cytol Pathol; 1993; 41(3-4):129-39. PubMed ID: 8279854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions.
    Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ
    Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
    Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
    Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiomatoid carcinoma and 'angiosarcoma' of the thyroid gland. A spectrum of endothelial differentiation.
    Mills SE; Gaffey MJ; Watts JC; Swanson PE; Wick MR; LiVolsi VA; Nappi O; Weiss LM
    Am J Clin Pathol; 1994 Sep; 102(3):322-30. PubMed ID: 8085556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary thyroid carcinoma and other rare types of thyroid carcinoma].
    Obara T
    Nihon Rinsho; 2007 Nov; 65(11):2087-91. PubMed ID: 18018575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemistry of the thyroid in surgical and cytologic specimens.
    Davila RM; Bedrossian CW; Silverberg AB
    Arch Pathol Lab Med; 1988 Jan; 112(1):51-6. PubMed ID: 3337618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin and calcitonin immunoreactivity in canine thyroid carcinomas.
    Moore FM; Kledzik GS; Wolfe HJ; DeLellis RA
    Vet Pathol; 1984 Mar; 21(2):168-73. PubMed ID: 6375099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.